Crystal Structure of an Anti-Ang2 CrossFab Demonstrates Complete Structural and Functional Integrity of the Variable Domain-Reference-Cited by-同舟云学术

Crystal Structure of an Anti-Ang2 CrossFab Demonstrates Complete Structural and Functional Integrity of the Variable Domain

Published:2013-04-17 Issue:4 Volume:8 Page:e61953
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fenn Sebastian,Schiller Christian B.,Griese Julia J.,Duerr Harald,Imhof-Jung Sabine,Gassner Christian,Moelleken Joerg,Regula Joerg Thomas,Schaefer Wolfgang,Thomas Markus,Klein Christian,Hopfner Karl-Peter,Kettenberger Hubert

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies;C Klein;MAbs,2012

2. Dual targeting strategies with bispecific antibodies;R Kontermann;MAbs,2012

3. Anatomy of the antibody molecule;EA Padlan;Mol Immunol,1994

4. The biological origin of antibody diversity;AR Williamson;Annu Rev Biochem,1976

5. Structure and function of immunoglobulins;HW Schroeder Jr;J Allergy Clin Immunol,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment;Frontiers in Immunology;2023-12-01

2. “Stapling” scFv for multispecific biotherapeutics of superior properties;mAbs;2023-04-19

3. Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors;Pharmaceutics;2022-11-11

4. Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer;International Journal of Molecular Sciences;2021-05-26

5. Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials;International Journal of Biological Macromolecules;2021-01